{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:21:14Z","timestamp":1773235274534,"version":"3.50.1"},"reference-count":25,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:sec>\n<jats:title>Object<\/jats:title>\n<jats:p>The study of patients with multiple neoplasms can yield valuable insight into the common pathogenesis of both diseases, as well as identify more subtle risk factors that might not be as readily apparent otherwise. The authors present an analysis of the prevalence of previously diagnosed extracranial malignancies at the time of meningioma diagnosis in 1228 patients evaluated at a single institution.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>All patients who underwent evaluation and\/or treatment for meningioma between 1991 and 2007 at the authors' institution were identified. The intake history and physical were assessed for any history of extracranial malignancy. Using the National Cancer Institute data, the authors calculated an expected cancer prevalence for their meningioma patient population, and compared this derived value to the observed rate of these cancers in this population.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>There were 1228 patients included in this study. A total of 50 patients (4.1%) with newly diagnosed meningioma had a history of an extracranial malignant tumor at the time of their initial meningioma diagnosis. In general, most malignancies did not differ in prevalence from their expected frequency in the population in the present study. Notable exceptions were acute leukemia (p &lt; 0.0001), and papillary thyroid carcinoma, which had a prevalence 2.5 times that expected in this population (p &lt; 0.05).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The data support a growing body of evidence suggesting an epidemiological link between papillary carcinoma of the thyroid and meningioma. Although the link between these tumors is not immediately apparent, it is possible that further exploration will yield interesting insight into the pathogenesis of both diseases.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2010.3.jns091975","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T14:15:20Z","timestamp":1272636920000},"page":"1115-1121","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of previous extracranial malignancies in a series of 1228 patients presenting with meningioma"],"prefix":"10.3171","volume":"113","author":[{"given":"Michael E.","family":"Sughrue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari J.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopal","family":"Shangari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"Parsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchel S.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"issue":"4","key":"b1-jns091975","series-title":"Neurosurg Focus","first-page":"E2","article-title":"Meningiomas: causes and risk factors","volume":"23","author":"Barnholtz-Sloan","year":"2007"},{"key":"b2-jns091975","series-title":"Oncol Rep","first-page":"485","article-title":"Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?","volume":"20","author":"Barresi","year":"2008"},{"key":"b3-jns091975","series-title":"J Neurooncol","first-page":"197","article-title":"Epidemiology and etiology of intracranial meningiomas: a review","volume":"29","author":"Bondy","year":"1996"},{"key":"b4-jns091975","series-title":"Stat Med","first-page":"425","article-title":"Estimating the completeness of prevalence based on cancer registry data","volume":"16","author":"Capocaccia","year":"1997"},{"key":"b5-jns091975","series-title":"Proc Natl Acad Sci U S A","first-page":"4463","article-title":"Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf\/Raf-1 complex and inhibition by the NF2 tumor suppressor protein","volume":"103","author":"Chadee","year":"2006"},{"key":"b6-jns091975","series-title":"Neurology","first-page":"969","article-title":"Recurrent meningioma: salvage therapy with long-acting somatostatin analogue","volume":"69","author":"Chamberlain","year":"2007"},{"key":"b7-jns091975","series-title":"Cancer","first-page":"1626","article-title":"The association between breast carcinoma and meningioma in women","volume":"94","author":"Custer","year":"2002"},{"key":"b8-jns091975","series-title":"Neuroepidemiology","first-page":"101","article-title":"Second primary tumors following a diagnosis of meningioma in Sweden, 1958\u20131997","volume":"29","author":"Davis","year":"2007"},{"key":"b9-jns091975","series-title":"Neurology","first-page":"267","article-title":"Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas","volume":"49","author":"Gutmann","year":"1997"},{"key":"b10-jns091975","series-title":"APMIS","first-page":"738","article-title":"Neoplasms of the central nervous system in Norway. V. Meningioma and cancer of other sites. An analysis of the occurrence of multiple primary neoplasms in meningioma patients in Norway from 1955 through 1986","volume":"97","author":"Helseth","year":"1989"},{"key":"b11-jns091975","series-title":"Cancer","first-page":"2052","article-title":"[(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial","volume":"115","author":"Iten","year":"2009"},{"key":"b12-jns091975","series-title":"Arch Neurol","first-page":"753","article-title":"Meningiomas are not significantly associated with breast cancer","volume":"49","author":"Jacobs","year":"1992"},{"key":"b13-jns091975","series-title":"Mol Cell Biol","first-page":"4250","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1 and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"James","year":"2009"},{"key":"b14-jns091975","series-title":"J Invest Dermatol","first-page":"1252","article-title":"BRAF polymorphisms and risk of melanocytic neoplasia","volume":"125","author":"James","year":"2005"},{"key":"b15-jns091975","series-title":"Gynecol Oncol","first-page":"807","article-title":"BRAF polymorphisms and the risk of ovarian cancer of low malignant potential","volume":"97","author":"Kelemen","year":"2005"},{"key":"b16-jns091975","series-title":"Cancer","first-page":"639","article-title":"Epidemiology of intracranial meningioma","volume":"72","author":"Longstreth","year":"1993"},{"key":"b17-jns091975","series-title":"Int J Epidemiol","first-page":"197","article-title":"Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program","volume":"29","author":"Merrill","year":"2000"},{"key":"b18-jns091975","series-title":"Thyroid","first-page":"889","article-title":"Epidemiology and primary prevention of thyroid cancer","volume":"12","author":"Nagataki","year":"2002"},{"key":"b19-jns091975","series-title":"Estimated Total Lifetime Prevalence Tables: SEER Cancer Statistics Review 1975\u20132006","author":"National Cancer Institute","year":"2009"},{"key":"b20-jns091975","series-title":"Thyroid Res","first-page":"1","article-title":"Expression of somatostatin receptor subtypes in human thyroid tumors: the immunohistochemical and molecular biology (RT-PCR) investigation","volume":"2","author":"Pisarek","year":"2009"},{"key":"b21-jns091975","series-title":"Cancer Res","first-page":"551","article-title":"Somatostatin receptors in human endocrine tumors","volume":"47","author":"Reubi","year":"1987"},{"key":"b22-jns091975","series-title":"Arch Pathol Lab Med","first-page":"1087","article-title":"Possible relation of osteopontin to development of psammoma bodies in human papillary thyroid cancer","volume":"122","author":"Tunio","year":"1998"},{"key":"b23-jns091975","series-title":"Kaohsiung J Med Sci","first-page":"334","article-title":"Expression of thyroid hormone receptors in intracranial meningiomas","volume":"19","author":"Wang","year":"2003"},{"key":"b24-jns091975","series-title":"Genes Chromosomes Cancer","first-page":"389","article-title":"NF2: the wizardry of merlin","volume":"38","author":"Xiao","year":"2003"},{"key":"b25-jns091975","series-title":"Endocr Rev","first-page":"742","article-title":"BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications","volume":"28","author":"Xing","year":"2007"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/113\/5\/article-p1115.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/113\/5\/article-p1115.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/113\/5\/article-p1115.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T04:53:31Z","timestamp":1679892811000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/113\/5\/article-p1115.xml"}},"subtitle":["Clinical article"],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":25,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/2010.3.jns091975","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}